about
Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive reviewMantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agentsPIM1 kinase phosphorylates the human transcription factor FOXP3 at serine 422 to negatively regulate its activity under inflammationA small-molecule inhibitor of PIM kinases as a potential treatment for urothelial carcinomasTargeting Pim kinases for cancer treatment: opportunities and challengesPim1 serine/threonine kinase regulates the number and functions of murine hematopoietic stem cellsPIM kinases as potential therapeutic targets in a subset of peripheral T cell lymphoma cases.Clinical and biological significance of PIM1 kinase in osteosarcoma.Pim-1 acts as an oncogene in human salivary gland adenoid cystic carcinomaBiased random walk model for the prioritization of drug resistance associated proteins.Pim-2 Kinase Influences Regulatory T Cell Function and Stability by Mediating Foxp3 Protein N-terminal PhosphorylationControl of Pim2 kinase stability and expression in transformed human haematopoietic cellsAbnormal hematopoietic phenotypes in Pim kinase triple knockout mice.Inhibition of Pim2-prolonged skin allograft survival through the apoptosis regulation pathway.The PIM family of serine/threonine kinases in cancer.PIM kinases: an overview in tumors and recent advances in pancreatic cancer.Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation.Targeted therapy of acute myeloid leukemia.Upregulation of PIM2 by Underexpression of MicroRNA-135-5p Improves Survival Rates of Skin Allografts by Suppressing Apoptosis of Fibroblast Cells.The role of PIM1 in the ibrutinib-resistant ABC subtype of diffuse large B-cell lymphoma.Molecular Subtyping in Diffuse Large B Cell Lymphoma: Closer to an Approach of Precision Therapy.A combination strategy to inhibit Pim-1: synergism between noncompetitive and ATP-competitive inhibitors.The PIM family of oncoproteins: small kinases with huge implications in myeloid leukemogenesis and as therapeutic targets.Role of PIM2 in allergic asthma.Pim kinase inhibitors for the treatment of cancer and possibly more.Mice Lacking Functional Fas Death Receptors Are Protected from Kainic Acid-Induced Apoptosis in the Hippocampus.Expression of PIM-1 in salivary gland adenoid cystic carcinoma: Association with tumor progression and patients' prognosis.
P2860
Q27304386-F642EFD1-CB03-4939-9C20-DFDA50E91107Q28075606-8E8004CD-B278-4B41-A652-327895F333CBQ28115749-12B7F6C8-3B7D-4334-8F50-3CC0E6DBEFA5Q28242549-B6F477D2-B796-4CAD-B339-56EBB15573ACQ28255361-F12A43E7-CA34-415A-8A6E-0E1FFAB8FDEAQ28588864-0503CA08-C5C6-4017-9214-70640EEF753BQ34489388-CF564548-06FD-4169-8D12-3FF98F120481Q34674917-67C57D54-242D-4182-922A-38C3BB394F90Q35005230-5A58A8B2-1D33-434A-BDA0-0DB8F8230239Q35679339-ABADF2EF-8095-4B9B-AC14-C8473AB3F1FAQ35953106-A618C04C-E479-4605-BF4B-910D2B94D329Q36353641-7C05E849-15FE-4E15-AA0A-8B05B1145979Q36722804-5FF33EB1-4E62-40B0-80E1-C83CA6AAA75FQ37727853-8023AA75-8FF1-414E-9447-2BCB2A85494DQ38098139-EF9C7469-D6BC-4AEB-ADF2-87275D7F7C3FQ38209606-C2F8CA34-1E0E-4380-865C-E4ED473BB443Q38266874-B397FA7C-8976-4913-9AC9-ED8A76F8A4EEQ38333251-6F0CC928-3084-47EB-9D55-23DEF680BEEDQ38722428-485CC30F-E17A-49B8-A91C-495095174CA1Q38728157-F1F6AF6B-3EE2-4B13-9A77-EBBB3E55AA23Q39147488-8E1DF171-0344-4ED5-9913-AEDD0ADA6AEAQ39189299-14119D1B-190B-4703-B3EA-E6B48CF9E44EQ41733002-B37A3BD9-5005-4095-A6AB-1BED3405A82AQ41930909-950E16A6-133F-4824-8688-854FA051A987Q41960744-3D912CCD-E9C9-40C0-BC72-8A2CFF1018B3Q48606528-57DA522E-8320-4E53-A4C5-ABD290D92D3AQ49225961-4B60F43F-C54E-40FF-97C6-41E28FAB76A7
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The PIM kinases in hematological cancers
@ast
The PIM kinases in hematological cancers
@en
The PIM kinases in hematological cancers
@nl
type
label
The PIM kinases in hematological cancers
@ast
The PIM kinases in hematological cancers
@en
The PIM kinases in hematological cancers
@nl
prefLabel
The PIM kinases in hematological cancers
@ast
The PIM kinases in hematological cancers
@en
The PIM kinases in hematological cancers
@nl
P2093
P2860
P3181
P356
P1476
The PIM kinases in hematological cancers
@en
P2093
Francis J Giles
Ronan T Swords
Yesid Alvarado
P2860
P3181
P356
10.1586/EHM.11.69
P407
P577
2012-02-01T00:00:00Z